spatial transcriptomics visium (Spatial Transcriptomics Inc)
Structured Review

Spatial Transcriptomics Visium, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spatial transcriptomics visium/product/Spatial Transcriptomics Inc
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Single-cell and spatial profiling highlights TB-induced myofibroblasts as drivers of lung pathology"
Article Title: Single-cell and spatial profiling highlights TB-induced myofibroblasts as drivers of lung pathology
Journal: The Journal of Experimental Medicine
doi: 10.1084/jem.20251067
Figure Legend Snippet: Overview of the single-cell and spatial data generated from TB-diseased and control lungs. (A) Schematic showing the experimental flow for the isolation of cells from human lung tissues, generation of single-cell libraries using Seq-Well S 3 . Four TB-negative and nine TB-positive lung samples were processed through scRNA-seq. Shown adjacent to the process flow is a low-dimensional embedding (UMAP) of the 19,632 cells passing quality control annotated with high-level cell types (middle) or detailed cell subtype (right). (B) 10x Visium platform workflow for spatial transcriptomics profiling on FFPE samples from TB-diseased lung resections. 21 of these samples come from current TB patients with detectable M.tb ; 9 came from post-TB patient, where bacteria are no longer detected in BAL TB culture after infection. Samples contain either granulomas, iBALTs, or lung LNs, representing different pathological states.
Techniques Used: Generated, Control, Isolation, Bacteria, Infection
Figure Legend Snippet: Spatial transcriptomics on TB-infected human lung samples and single-cell deconvolution. (A) H&E staining on all 30 lung samples from patients previously infected with TB. Scale bars: 800 μm. Identical images for pid_0037, pid_177, pid_0186, pid_187, pid_0192, pid_199, pid_0209, and pid_304. (B) Examples of manual annotation on granuloma structures on H&E staining images. Scale bars: 800 μm.
Techniques Used: Infection, Staining
Figure Legend Snippet: Single-cell transcriptomic reveals heterogeneity within neutrophil populations with disease-specific difference. (A) Neutrophil ( n = 2,963) subclustering reveals three subclusters (left), also colored by patient ID (middle) and disease condition (right). (B) Volcano plot of differential gene expression results of each neutrophil subcluster compared with the rest. Y axis shows −log10 (BH-adjusted P value); x axis shows log2 fold change between cells in subcluster and outside the subcluster. (C) Heatmap of subtype top 10 differentially expressed (DE) genes in each of the neutrophil subcluster. (D) Expression of marker genes in neutrophil subclusters by disease conditions. (E) Fisher’s exact test on abundance of detailed neutrophil subclusters between TB conditions. Statistical annotations: fold-change >2 (ΔΔ). (F) Cell2loc imputed neutrophil abundance distribution on the Visium dataset grouped by TB and granuloma status (Materials and methods). The 5% quantile of the estimated posterior distribution of cell abundance at each Visium spot is displayed, representing the value of cell abundance that the model has high confidence in. Two-sided Mann–Whitney U test without correction were used for statistical testing. ****: P < 0.0001.
Techniques Used: Gene Expression, Expressing, Marker, MANN-WHITNEY
Figure Legend Snippet: Single-cell transcriptomic reveals heterogeneity within monocyte and macrophage populations with disease-specific difference. (A) Monocyte/macrophage ( n = 8,318) subclustering reveals 10 subclusters (left), also colored by patient ID (middle) and disease condition (right). (B) Heatmap of subtype top 10 DE genes in each of the monocyte/macrophage subcluster. (C) Expression of marker genes in monocyte/macrophage subclusters by disease conditions. (D) Two-sided Fisher’s exact test on abundance of detailed macrophage (left) and monocyte (right) subclusters between TB conditions. Holm’s method was applied to adjust P values for multiple-testing correction. Statistical annotations: P value < 0.05 (*), P value < 0.01 (**), P value < 0.001 (***), fold-change >1 (Δ), fold-change >2 (ΔΔ), and fold-change <1 (∇). (E) Cell2loc imputed macrophage (left) and monocyte (right) abundance distribution on the Visium dataset grouped by TB and granuloma status (Materials and methods). The 5% quantile of the estimated posterior distribution of cell abundance at each Visium spot is displayed, representing the value of cell abundance that the model has high confidence in. Two-sided Mann–Whitney U test without correction were used for statistical testing. Statistical annotations: P value < 0.0001 (****). (F) Similar to E, but grouped by TB status and HIV status.
Techniques Used: Expressing, Marker, MANN-WHITNEY
Figure Legend Snippet: Deconvolution of bulk human LN dataset and fibroblast in spatial and single-cell dataset. (A) Dot plot showing distribution of cell type proportion from deconvolution results on each bulk RNA-seq human LN TB granuloma sample, separated by cell type and colored by TB conditions. Only cell types with significant difference between TB conditions are shown. Two-sided T test with Bonferroni correction was used to compare the means. Statistical annotations: P value < 0.05 (*) and P value < 0.01 (**). (B) Cell2loc imputed fibroblast abundance distribution on the Visium dataset group by TB and granuloma status (Materials and methods). The 5% quantile of the estimated posterior distribution of cell abundance per Visium spot is displayed, representing the value of cell abundance that the model has high confidence in. Two-sided Mann–Whitney U test without correction were used for statistical testing. P value < 0.0001 (****); P value > 0.05 (ns). (C) Same as B, but grouped by HIV and TB status. (D) Bar plot of patient distribution in each fibroblast subcluster. (E) UMAP embedding of fibroblasts colored by HIV status of the sample.
Techniques Used: RNA Sequencing, MANN-WHITNEY
Figure Legend Snippet: Spatial transcriptomics analysis on post- and current TB lung resections. (A) Heatmap showing the expression of human TB-myofibroblast gene signature and SPP1 + CHI3L1 + macrophage markers on selective tissue slides from patients who are post-TB (top) or current TB (bottom), alongside paired H&E staining (these H&E stains are also shown in together with those other samples used for spatial transcriptomics not shown here). (B) Distribution of human TB-myofibroblast signature expression on the spatial cohort. HIV statuses are shown in different shades of blue for positive or negative. Two-sided Mann–Whitney U test without correction was used for statistical testing. Statistical annotation: P value < 0.0001 (****). (C) Distribution of SPP1 + CHI3L1 + macrophage markers and human TB-myofibroblast signature on the spatial data across all Visium spots. Left two panels: Manual segmentation of the granuloma structure was done to allow separation of the Visium slide into three different regions: in granuloma, on granuloma border (cuff), and outside of granuloma (Materials and methods). Right two panels: The same as left panels with the exception that “on border” = True means on granuloma cuff and False means the rest. Two-sided Mann–Whitney U test without correction was used for statistical testing. Statistical annotation: P value < 0.0001 (****). (D) Correlation between human TB-myofibroblast signature and all macrophage subpopulations’ markers. Each circle represents a Visium sample. Boxplot of the Pearson’s r distribution is shown for each macrophage subtype. Mann–Whitney U test without correction were used for statistical testing. Statistical annotation: P value < 0.0001 (****). (E) Spatially informed ligand–receptor (L–R) analysis using LIANA+ on Visium samples. Examples are shown where SPP1(L)–CD44(R) interactions are being nominated as top L–R pairs. H&E overlaid with pathology annotation for granuloma structures are shown next to heatmap of L–R interaction scores, which are calculated at each Visium spot using spatially weighted Cosine similarity (Materials and methods).
Techniques Used: Expressing, Staining, MANN-WHITNEY

![Comparative spatial multi-omics analysis of acute myeloid leukemia patients’ bone marrow and extramedullary tissues (A) Schematic representation of the study workflow. Paired bone marrow (BM) samples (BM1 and BM2) and extramedullary (EM) samples (EM1, from skin; and EM2, from lymph node) from 2 newly diagnosed patients with acute myeloid leukemia (AML) (PT1 and PT2) were fixed in formalin and embedded in paraffin (FFPE) and then sectioned for use in <t>Visium</t> assays (v1 and v2), and Opal multiplex fluorescent immunohistochemistry (mfIHC). The Visium spatial <t>transcriptomics</t> (ST) results were validated using GeoMx digital spatial profiling (DSP) with tissue microarrays (TMAs) of samples from 3 newly diagnosed patients with AML (PT3, PT4, and PT5). An additional 4 AML bone marrow samples that performed the Visium gene and protein expression assay are used as a validational cohort (PT6, PT7, PT8, and PT9). Image created with BioRender ( https://biorender.com ). (B) Uniform manifold approximation and projection (UMAP) plot showing our reference map consisted of 79,029 cells collected from 9 healthy BM donors and 7 patients with AML with diploid cytogenetics to match the patient cytogenetic profiles, and included both newly generated scRNA data and previous works. This map consisted of 21 cell types, including T cells (CD4 + and CD8 + naive, effector, and memory T cells, T regulatory [Treg] cells, and unconventional T cells), other immune cells (Natural killer [NK] cells, B cells and plasma cells), hematopoietic progenitors (Hematopoietic stem cells [HSCs], common lymphoid progenitors [CLPs], granulocyte-monocyte progenitors [GMPs]), myeloid cells (megakaryocytes/platelets, monocytes, early and late erythroid cells, conventional and plasmacytoid dendritic cells) and leukemic (AML) cell populations. (C) Immunohistochemical staining of CD11c, MPO, and CD3e on BM1 sections that were used for histopathological annotation. The scale bar for the main tissue panels represents 1 mm. The scale bar for the zoomed-in panels, corresponding to the boxed regions, represents 100 μm. (D) Unsupervised clustering and pathology annotation for the projected spatial map of BM1, revealing 3 distinct regions with an adjusted rand index (ARI) of 0.46. (E) Spatial deconvolution of BM1 tissue, showing erythroid and AML cell populations, with CD11c immunohistochemistry (IHC) overlaid on an image of hematoxylin and eosin (H&E)-staining. The dotted red lines represent regions enriched for the erythroid cell population; dotted black lines, regions enriched for the AML cell population; and solid lines, regions that overlapped with other tissue sections. (F) Heatmap of Z score normalized canonical markers in pathology annotations, with matching unsupervised cluster distributions represented as a pie chart. HBB, HBD, HBA2, GATA1/2 are erythroid genes and S100A12, FCGR3A, CD14, MS4A7, and , CD33 are monocyte/leukemic genes. (G) Representative overlay of Visium H&E staining with Opal mfIHC and the generated spot-level data for CD33, CD71, CXCL12, CXCR4, CD68, and IL-6. Boxes illustrate magnified regions showing concordance between transcript-level (Visium) and protein-level (Opal) signals at the spot level. (H) Phenotype staining on near-adjacent tissue sections for markers of leukemic (CD33), monocytic (CD68), and erythroid (CD71) populations. DAPI was used as a nuclear counterstain. The spatial distribution of these markers corroborates ST-based spot deconvolution. Scale bars: 1 mm (whole-slide panels) and 100 μm (selected region panels). (I) Box and spatial plots of mfIHC staining intensities for phenotypic markers across ST-defined clusters in BM1, highlighting the enrichment of leukemic and monocytic populations in cluster 3 and that of erythroid populations in cluster 2 at BM1. Scale bars: 1 mm (whole-slide panels) and 100 μm (selected region panels). ns, not significant. ∗∗∗∗ p < 0.0001, Wilcoxon rank-sum test.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6006/pmc12796006/pmc12796006__gr1.jpg)
